Project Number 3RF1AG072052-01S1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches Research Categorization Primary Disease / Condition Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies c. C9ORF-72 and Progranulin Researcher and Organization Principal Investigator CONKLIN, BRUCE R. Principal Investigator First Name BRUCE R Principal Investigator Last Name CONKLIN Awardee Organization J. DAVID GLADSTONE INSTITUTES Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PA-21-071: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) FY Overall Cost $239,309 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official OPANASHUK, LISA A
